A longitudinal study of histologic and immunohistologic changes in an experimental model of sclerosing cholangitis*
Pierre Bédossa(Régie Autonome des Transports Parisiens (France)), M Huguier(Sorbonne Université), E. Martin(Institut de Cancérologie de l'Ouest), Josette Bacci(Institute of Oriental Manuscripts), S Houry(Sorbonne Université), G Lemaigre(Institute of Oriental Manuscripts)
Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
January 1, 1989
Cited by 5
Related Papers
NASH limits anti-tumour surveillance in immunotherapy-treated HCC
|Nature|2021|1.3k
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2019|1.2k
Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
|Gastroenterology|2016|1k
A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis
|Hepatology|2012|405
Liver extracellular matrix in health and disease
|The Journal of Pathology|2003|299